Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug authorized in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults . It's functions as a prodrug, meaning https://sandoz-lisdexamfetamine-668421.blog4game.com/730295/lisdexamfetamine-in-canada-a-detailed-guide